CD40 Ligand Deficiency: Neurologic Sequelae With Radiographic Correlation

Pediatric Neurology

Volumn 41, Issue 6, 2009, Pages 419-427

  Bishu, Shrinivas ^a   Madhavan, Deepak ^b   Perez, Phillip ^c   Civitello, Lucy ^d   Liu, Shuying ^e   Fessler, Margaret ^e   Holland, Steven M ^e   Jain, Ashish ^e   Pao, Maryland ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PLECONARIL;

ARTICLE; BRAIN DISEASE; CD40 LIGAND DEFICIENCY; CENTRAL NERVOUS SYSTEM INFECTION; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; COGNITION; DISEASE COURSE; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ENCEPHALITIS; ENTEROVIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; INFANT; MALE; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; X LINKED AGAMMAGLOBULINEMIA;

BRAIN; CD40 LIGAND; CHILD, PRESCHOOL; COGNITION DISORDERS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEURODEGENERATIVE DISEASES;

EID: 70449476245     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2009.07.003     Document Type: Article

References (41)

1. Seyama K., Nonoyama S., Gangsaas I., et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92 (1998) 2421-2434
2. Noelle R.J., Roy M., Shepherd D.M., Stamenkovic I., Ledbetter J.A., and Aruffo A.A. 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A 89 (1992) 6550-6554
3. Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., and Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 22 (1992) 2573-2578
4. Levy J., Espanol-Boren T., Thomas C., et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131 (1997) 47-54
5. Cunningham C.K., Bonville C.A., Ochs H.D., et al. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr 134 (1999) 584-588
6. Winkelstein J.A., Marino M.C., Ochs H., et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82 (2003) 373-384
7. Leiva L.E., Junprasert J., Hollenbaugh D., and Sorensen R.U. Central nervous system toxoplasmosis with an increased proportion of circulating γδ T cells in a patient with hyper-IgM syndrome. J Clin Immunol 18 (1998) 283-290
8. Blaeser F., Kelly M., Siegrist K., et al. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol (Orlando, Fla) 117 (2005) 231-237
9. Hecht J.H., Glenn O.A., Wara D.W., and Wu Y.W. JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. Pediatr Neurol 36 (2007) 186-189
10. Aschermann Z., Gomori E., Kovacs G.G., et al. X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy. Arch Neurol 64 (2007) 273-276
11. Suzuki H., Takahashi Y., and Miyajima H. Progressive multifocal leukoencephalopathy complicating X-linked hyper-IgM syndrome in an adult. Intern Med 45 (2006) 1187-1188
12. Rotbart H.A., and Webster A.D. Pleconaril Treatment Registry Group. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 32 (2001) 228-235
13. Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am 28 (2008) 413-437 x
14. McKinney Jr. R.E., Katz S.L., and Wilfert C.M. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9 (1987) 334-356
15. Rudge P., Webster A.D., Revesz T., et al. Encephalomyelitis in primary hypogammaglobulinaemia. Brain 119 (1996) 1-15
16. Orange J.S., Hossny E.M., Weiler C.R., et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. [Erratum in: J Allergy Clin Immunol 2006;117:1483. Dosage error in article text.]. J Allergy Clin Immunol 117 4 Suppl (2006) S525-S553
17. Winkelstein J.A., Marino M.C., Lederman H.M., et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85 (2006) 193-202
18. Wilfert C.M., Buckley R.H., Mohanakumar T., et al. Persistent and fatal central-nervous-system Echovirus infections in patients with agammaglobulinemia. N Engl J Med 296 (1977) 1485-1489
19. Misbah S.A., Spickett G.P., Ryba P.C., et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol 12 (1992) 266-270
20. Halliday E., Winkelstein J., and Webster A.D. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect 46 (2003) 1-8
21. Erlendsson K., Swartz T., and Dwyer J.M. Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin. N Engl J Med 312 (1985) 351-353
22. Dwyer J.M., and Erlendsson K. Intraventricular gamma-globulin for the management of enterovirus encephalitis. Pediatr Infect Dis J 7 5 Suppl (1988) S30-S33
23. Weiner L.S., Howell J.T., Langford M.P., et al. Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis 140 (1979) 858-863
24. Debiasi R.L., and Tyler K.L. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 17 (2004) 903-925
25. Ziegner U.H., Kobayashi R.H., Cunningham-Rundles C., et al. Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol 102 (2002) 19-24
26. Subauste C.S., Wessendarp M., Sorensen R.U., and Leiva L.E. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol 162 (1999) 6690-6700
27. Whitmire J.K., Slifka M.K., Grewal I.S., Flavell R.A., and Ahmed R. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. [Erratum in: J Virol 1997;71:1736]. J Virol 70 (1996) 8375-8381
28. + cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J Virol 72 (1998) 7440-7449
29. + effector T cell responses. J Immunol 164 (2000) 3689-3697
30. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., and Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393 (1998) 480-483
31. + cytotoxic T lymphocytes. J Exp Med 191 (2000) 541-550
32. Ameratunga R., Lederman H.M., Sullivan K.E., et al. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr 131 (1997) 147-150
33. de Saint Basile G., Geissmann F., Flori E., et al. Severe combined immunodeficiency caused by deficiency in either the δ or the ε{lunate} subunit of CD3. J Clin Invest 114 (2004) 1512-1517
34. + T lymphocyte deficiency and impaired lymphocyte activation. Clin Exp Immunol 90 (1992) 390-393
35. de la Salle H., Hanau D., Fricker D., et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency [Erratum in: Science 1994;266:1464]. Science 265 (1994) 237-241
36. Notarangelo L., Casanova J.L., Conley M.E., et al. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117 (2006) 883-896
37. Klein C., Lisowska-Grospierre B., LeDeist F., Fischer A., and Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 123 (1993) 921-928
38. van Benten I., Koopman L., Niesters B., et al. Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants. Pediatr Allergy Immunol 14 (2003) 363-370
39. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 (2001) 719-724
40. Wang D., Coscoy L., Zylberberg M., et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 99 (2002) 15687-15692
41. Wang D., Urisman A., Liu Y.T., et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 1 2 (2003) e2